|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| NET SALES | |||
| Cost of sales | |||
| GROSS MARGIN | |||
| OPERATING EXPENSES AND INCOME | |||
| Selling, general and administrative expenses | |||
| Research, development and engineering expenses | |||
| Equity, royalty and interest income from investees | |||
| Other operating expense, net | |||
| OPERATING INCOME | |||
| Interest expense | |||
| Other income, net | |||
| INCOME BEFORE INCOME TAXES | |||
| Income tax expense | |||
| NET INCOME | |||
| PER SHARE DATA: | |||
| Weighted-average shares for basic EPS (in shares) | |||
| Weighted-average shares for diluted EPS (in shares) | |||
| Basic earnings per share (in dollars per share) | |||
| Diluted earnings per share (in dollars per share) |
Loading...
